Claritas Rx unveiled its Access Analytics platform to address fragmented data in market access operations for commercial life science companies. The software consolidates real-time data from payers, specialty pharmacies, reimbursement hubs, and patient support systems, enabling firms to identify treatment barriers, detect market trends, and refine access strategies swiftly. Claritas Rx CEO Mike Fitzgibbons emphasized the platform’s capability to provide actionable, timely insights, particularly for specialty and rare diseases, enhancing patient support and therapy initiation.